Diphtheria Outbreak Returns to Australia After 50 Years
Australia is experiencing a significant diphtheria outbreak, marking the first in nearly 50 years. Cases have surged, primarily in Western Australia's Kimberley region and the Northern Territory, affecting both children and adults. Public health authorities are urging vigilance and emphasizing vaccination as the key preventive measure against this serious, potentially deadly bacterial infection.
Key Highlights
- Diphtheria outbreak declared in Australia after a 50-year absence.
- Cases are concentrated in Western Australia and the Northern Territory.
- Both children and adults are contracting the disease.
- Vaccination is the most effective way to prevent diphtheria.
- Authorities urge public vigilance and prompt medical attention.
Australia is grappling with a resurgence of diphtheria, a serious bacterial infection not seen in significant numbers for nearly 50 years. The current outbreak is primarily concentrated in the Kimberley region of Western Australia and the Northern Territory, with cases also reported in South Australia and Queensland. This alarming development has prompted public health alerts across multiple jurisdictions.
The first cases began to surface in late 2025, and numbers have rapidly increased, with over 30 confirmed cases reported across Western Australia by April 2026, predominantly in the Kimberley region. Similarly, the Northern Territory has seen a significant rise, with numerous cases of both respiratory and cutaneous diphtheria. The outbreak is concerning as it affects individuals across all age groups, including children and adults, underscoring that no one is immune.
Diphtheria is caused by the bacterium *Corynebacterium diphtheriae*, which produces a toxin that can lead to severe illness. There are two main forms: respiratory diphtheria, which affects the throat and airways, and cutaneous diphtheria, which causes skin sores or ulcers. While skin diphtheria is generally less severe, it can still spread the bacteria and lead to more serious complications if untreated. The hallmark symptom of respiratory diphtheria is a thick, grey membrane that forms in the throat, making breathing and swallowing difficult. Complications can be severe and include airway obstruction, heart damage, nerve damage, kidney failure, paralysis, and even death. Historically, before widespread vaccination, diphtheria was a leading cause of death in children. Even with treatment, the mortality rate for respiratory diphtheria can be as high as 1 in 10.
The re-emergence of diphtheria in Australia is particularly concerning given the success of vaccination programs in controlling the disease for decades. Diphtheria vaccination has been a part of Australia's National Immunisation Program (NIP) for many years, with high coverage rates in children. However, experts suggest that potential declines in vaccination rates, especially among certain populations or age groups, may have contributed to this outbreak. Travel from countries where diphtheria is more common, such as Southeast Asia and Papua New Guinea, is also considered a potential factor in its reintroduction.
Public health authorities are urging the public to be vigilant and to seek immediate medical attention if diphtheria symptoms are suspected. Vaccination is emphasized as the most effective preventive measure against the disease. The diphtheria vaccine is available as part of routine childhood immunisation schedules and booster doses are recommended for adults. Health departments are actively implementing strategies such as contact tracing, providing information to the public, and encouraging vaccination booster campaigns in affected communities.
Medical treatment for diphtheria typically involves diphtheria antitoxin to neutralize the circulating toxin and antibiotics to kill the bacteria. Prompt treatment is crucial for reducing the risk of complications and death. Patients are usually isolated in hospital to prevent further spread.
The current outbreak serves as a stark reminder of the importance of maintaining high vaccination coverage to prevent the resurgence of vaccine-preventable diseases. While diphtheria was once considered largely eradicated in Australia, its return highlights the ongoing need for public health vigilance and robust immunisation programs.
Frequently Asked Questions
What is diphtheria and how does it spread?
Diphtheria is a serious bacterial infection caused by *Corynebacterium diphtheriae*. It primarily affects the nose and throat, forming a thick, grey membrane that can obstruct breathing. It spreads through respiratory droplets from coughing or sneezing, or direct contact with infected wounds or sores.
What are the symptoms of diphtheria?
Symptoms typically appear 2-5 days after exposure and can include a sore throat, mild fever, swollen neck glands, hoarseness, difficulty breathing or swallowing, and a thick, grey coating in the throat. Cutaneous diphtheria can cause skin sores or ulcers.
Why is this diphtheria outbreak significant in Australia?
This outbreak is significant because diphtheria was largely eradicated in Australia due to widespread vaccination and had not been seen in nearly 50 years. Its resurgence highlights the importance of maintaining high vaccination rates and public health vigilance.
How can diphtheria be prevented?
The most effective way to prevent diphtheria is through vaccination. Diphtheria vaccines are available as part of routine childhood immunization schedules, and booster doses are recommended for adults. Practicing good hygiene and seeking prompt medical attention if symptoms appear are also important.
What is the treatment for diphtheria?
Treatment involves diphtheria antitoxin to neutralize the toxin and antibiotics to kill the bacteria. Hospitalization and isolation are necessary to prevent spread, and prompt medical attention is crucial to reduce the risk of severe complications and death.
